These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6233207)

  • 1. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals.
    Naeim F; Walford RL
    J Gerontol; 1980 Sep; 35(5):650-5. PubMed ID: 6448891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.
    Duijndam-van den Berge M; Goekoop JG
    J Neurol Neurosurg Psychiatry; 1986 May; 49(5):595-8. PubMed ID: 2940340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome.
    Cossarizza A; Ortolani C; Forti E; Montagnani G; Paganelli R; Zannotti M; Marini M; Monti D; Franceschi C
    Blood; 1991 Mar; 77(6):1263-70. PubMed ID: 1825795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities.
    Rabinowe SL; Rubin IL; George KL; Adri MN; Eisenbarth GS
    J Autoimmun; 1989 Feb; 2(1):25-30. PubMed ID: 2526634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
    Singh VK; Fudenberg HH; Brown FR
    Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies of Down's syndrome and Alzheimer's disease.
    Walford RL
    Ann N Y Acad Sci; 1982; 396():95-106. PubMed ID: 6295240
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocyte subpopulations in Down's syndrome].
    Mori M; Zaike Y; Takeda T
    Rinsho Ketsueki; 1986 Oct; 27(10):1829-33. PubMed ID: 2950258
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphocyte capping in Down's syndrome and Alzheimer's disease.
    Brohée D
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):370. PubMed ID: 2951500
    [No Abstract]   [Full Text] [Related]  

  • 14. Aging, longevity, and cancer: studies in Down's syndrome and centenarians.
    Franceschi C; Monti D; Cossarizza A; Fagnoni F; Passeri G; Sansoni P
    Ann N Y Acad Sci; 1991; 621():428-40. PubMed ID: 1830464
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte surface phenotypes in Down's syndrome.
    Bertotto A; Lungarotti MS; Gentili F; Vaccaro R
    Int J Tissue React; 1984; 6(3):219-21. PubMed ID: 6237071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome.
    Cossarizza A; Monti D; Bersani F; Scarfi MR; Zanotti M; Cadossi R; Franceschi C
    Aging (Milano); 1991 Sep; 3(3):241-6. PubMed ID: 1837237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life span changes in the averaged evoked responses of Down's syndrome and nonretarded persons.
    Callner DA; Dustman RE; Madsen JA; Schenkenberg T; Beck EC
    Am J Ment Defic; 1978 Jan; 82(4):398-405. PubMed ID: 146432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related studies of SIg, Leu-4 and concanavalin A receptor densities and capping in human lymphocytes.
    Cohen HJ; Boland KM; Rao KM
    Mech Ageing Dev; 1991 Jun; 59(3):253-62. PubMed ID: 1921516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.